Migraines were once thought to be caused by widening of blood vessels in the head, but research showed the real cause is something else - and it can be treated ...

Thirteen percent of Americans—about 38 million people—suffer from migraine, and every one of them has a different experience with the condition. Treatment has to be as individualized as they are.

Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief and 36% (9/25) reported consistent freedom from headache. The Food and Drug Administration (FDA) has ...

Migraine sufferers are no strangers to major headaches. The onset of a migraine can be painful, disorienting and sometimes even debilitating. During National Migraine and Headache Awareness Month, Fox ...

Learn how prochlorperazine (Compazine) is used to treat migraine-related nausea and why it’s a key ingredient in the ‘migraine cocktail.’ ...

As CGRP-targeted therapies move into wider use, new data are beginning to clarify their role in special populations, the value of switching agents when one fails, and their long-term vascular safety.

Migraine meds letting you down? Maybe it's time for a change. Treatments like nonsteroidal anti-inflammatory drugs (NSAIDs) and triptans can be very effective, but they don’t work for everyone. Even ...

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

In a head-to-head comparison, researchers assessed the effectiveness of migraine medications. Triptans, ergots, and antiemetics were among the most effective acute treatments for individuals with ...

Neurologist Dr. Susan Lee answers common questions about new treatments for migraine and where the future of migraine research is headed. Standard treatments taken at the onset of a migraine episode ...

Migraines are increasing in frequency and intensity among Americans: Could climate change be a reason? Although the number of Americans who have migraines has remained stable for the last 30 years, ...

Nerivio is a wireless remote electrical neuromodulation device that is self-applied to the upper arm. Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief ...